TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 0.5 mg prolonged-release capsule blister pack

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

tacrolimus monohydrate, Quantity: 0.511 mg (Equivalent: tacrolimus, Qty 0.5 mg)

متاح من:

Sandoz Pty Ltd

الشكل الصيدلاني:

Capsule, modified release

تركيب:

Excipient Ingredients: ethylcellulose; hypromellose; lactose monohydrate; magnesium stearate; sunset yellow FCF; allura red AC; brilliant blue FCF; titanium dioxide; Gelatin; tartrazine; propylene glycol; butan-1-ol; sunset yellow FCF aluminium lake; isopropyl alcohol; brilliant blue FCF aluminium lake; allura red AC aluminium lake; lecithin; simethicone; ethanol; Shellac; strong ammonia solution; sulfuric acid

طريقة التعاطي:

Oral

الوحدات في الحزمة:

50, 60, 100, 30

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

TACROLIMUS XR SANDOZ are indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

ملخص المنتج:

Visual Identification: Capsules with light brown body and light yellow cap imprinted in black with 0.5mg; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

الوضع إذن:

Registered

تاريخ الترخيص:

2022-08-05